Exact Sciences Collapses On 'Alarming' Guidance Cut. Is The Growth Story Broken?
Exact Sciences stock collapsed Wednesday after the Cologuard maker reported light third-quarter sales and cut its full-year outlook. Continue reading View comments
57.62 | |
56.55 | |
- | |
57.85 | |
55.93 | |
38.145-68.94 | |
12 100 M | |
0 | |
0 | |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Exact Sciences stock collapsed Wednesday after the Cologuard maker reported light third-quarter sales and cut its full-year outlook. Continue reading View comments
MADISON, Wis., October 08, 2024--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release it...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: